跳至主要内容
临床试验/ACTRN12622000902796
ACTRN12622000902796尚未招募未知

Feasibility and preliminary efficacy of N-Acetylcysteine for loss of control eating: an open-label study

Florey Institute of Neuroscience and Mental Health0 个研究点目标入组 36 人开始时间: 2022年6月24日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Adult (age >18 years) with loss of control eating, defined as at least one episode of loss of control eating in the past month as assessed using the Eating Loss of Control Scale
  • - Negative pregnancy test at baseline for participants of childbearing potential

排除标准

  • - Participant with cognitive impairment which will hinder their ability to provide informed consent or to complete the surveys
  • - Participants who are pregnant or lactating or planning to become pregnant during the study
  • - Use of any medication containing N-Acetylcysteine or other contraindicated medications within 4 weeks prior to enrolment,
  • - Known previous hypersensitivity to N-Acetylcysteine
  • - Any serious medical illness that N-Acetylcysteine may adversely affect.
  • - Surgery within the past 28 days
  • - Currently using or planning to use a formal weight loss program during the study

研究者

发起方
Florey Institute of Neuroscience and Mental Health

相似试验